Clinical Trial Update: Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study of a 90-day intravaginal ring containing tenofovir; results have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir (Tenofovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2025-11-13